Skip to main content

Qiagen N.V. – QIAGEN reaches milestone with its kits used to process more than three billion biological samples to date

By August 25, 2021News
Qiagen Logo

Qiagen Logo

GERMANTOWN, Md. & HILDEN, Germany–(BUSINESS WIRE)– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the number of biological samples processed with consumables kits has passed the three billion mark – a record that underlines its leadership in enabling molecular laboratories to gain valuable insights in research, combatting diseases and forensics.

This milestone particularly underscores QIAGEN’s standout position in sample preparation, the most crucial stage of molecular testing at which DNA, RNA or proteins are extracted from human samples. QIAGEN’s sample prep kits have become the gold standard in sample extraction and earned over 200,000 references in academic studies. With more than 500 consumable kits and automated systems such as QIAsymphony, QIAcube Connect, QIAcube HT and EZ1, QIAGEN is the most trusted brand in sample preparation.

 

{iframe}https://corporate.qiagen.com/newsroom/press-releases/press-release-details/2021/QIAGEN-Reaches-Milestone-With-Its-Kits-Used-to-Process-More-Than-Three-Billion-Biological-Samples-to-Date/default.aspx{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.